510(k) device
CanGaroo Envelope (small)
Aziyo Biologics, Inc. · Mesh, Surgical (FTM, Class II) · First FDA decision Oct 25, 2017, newest Jun 15, 2020Breast reconstruction and augmentationHernia
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
5
Naming "CanGaroo Envelope"
MAUDE reports
98
Brand "CanGaroo Envelope", since 2015
PubMed studies
3
Mentioning "CanGaroo Envelope"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CanGaroo Envelope (small)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K201313 · Decided Jun 15, 2020 · 28 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
K192616 · Decided Oct 21, 2019 · 28 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
K173242 · Decided Oct 25, 2017 · 19 days after receipt
Device type: Mesh, Surgical (FTM) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Wrong Surgical or Other Invasive Procedure Performed on a PatientNational determinationOn the books140.6Updated Nov 5, 2026
- Surgical or Other Invasive Procedure Performed on the Wrong PatientNational determinationOn the books140.8Updated Sep 25, 2026
- Surgical or Other Invasive Procedure Performed on the Wrong Body PartNational determinationOn the books140.7Updated Sep 25, 2026
- Cryosurgical Salvage Therapy for Recurrent Prostate CancerNational analysisReview closedCAG-00064NUpdated Sep 14, 2026
- Electroencephalographic Monitoring During Surgical Procedures Involving the Cerebral VasculatureNational determinationOn the books160.8Updated Jan 23, 2017
- Surgical Treatment of NailsProposed local determinationProposedDL40462Noridian Healthcare Solutions, LLCUpdated Sep 23, 2026
- Minimally-invasive Surgical (MIS) Fusion of the Sacroiliac (SI) JointLocal determinationIn effectL36406Wellpoint FederalUpdated Jul 14, 2026
- Surgical Treatment of Obstructive Sleep Apnea (OSA)Local determinationIn effectL34526WPS Insurance CorporationUpdated Jun 16, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "CanGaroo Envelope", any status and sponsor, newest update first.
Elutia Inc.Not on our public-company list
NCT04299282 · 0 participants · Start Jun 2021 · Primary completion Dec 2021
Device: CanGaroo · For: Heart Diseases; Cardiac Disease
- CanGaroo® Registry StudyCompleted
Elutia Inc.Not on our public-company list
NCT04846127 · 500 participants · Start May 25, 2021 · Primary completion Apr 17, 2023
Device: CanGaroo Envelope · For: Arrhythmias, Cardiac
Sites: Little Rock, Arkansas; Daytona Beach, Florida; Delray Beach, Florida · 23 sites in all
Elutia Inc.Not on our public-company list
NCT04645173 · 46 participants · Start Feb 2, 2021 · Primary completion Oct 31, 2023
Device: CIED envelope · For: Cardiac Disease
Sites: Chandler, Arizona; Bay Pines, Florida; Jacksonville, Florida · 11 sites in all
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CanGaroo Envelope", and for the whole product code for context.
This brand
98 reports: 2 malfunction, 96 injury, 0 death
Whole product code FTM
5,291 reports: 219 malfunction, 5,021 injury, 34 death
Newest reports for this brand
- CanGaroo EnvelopeInjury
2124215-2026-51312 · Received Sep 26, 2026 · Event dated Sep 2, 2026
Device type: Mesh, Surgical (FTM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
- CanGaroo EnvelopeInjury
2124215-2026-51274 · Received Sep 25, 2026 · Event dated Sep 1, 2026
Device type: Mesh, Surgical (FTM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
- CanGaroo EnvelopeInjury
2124215-2026-50739 · Received Sep 23, 2026 · Event dated Aug 7, 2026
Device type: Mesh, Surgical (FTM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Unspecified Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0040-2020 · Started Aug 21, 2019
Reason given: Possible suture brittleness or breakage along the Envelope seam before the expiration date of the device.
Cause as FDA categorized it: Under Investigation by firm · Device type: Mesh, Surgical (FTM)
Published research
The most relevant PubMed records for "CanGaroo Envelope"[tiab]. The summary above synthesizes these.
- Efficacy of Antimicrobial Envelopes in Preventing Cardiac Implantable Electronic Device Infection: Systematic Review and Meta-Analysis.
Mahajan A, Mehta O, Stuart R, et al. · Korean Circ J · 2026
- Pacemaker Pocket Stabilization Utilizing a Novel Envelope and a Three-Point Anchoring Technique.
Pothineni NVK, Kumareswaran R, Schaller RD · Cureus · 2021Case Reports
- Patient Profiles in the Utilization of the CanGaroo® Envelope.
Nayak H, Beaser AD, Aziz ZA · Cureus · 2021
Other devices of this type
Also filed under product code FTM.
- Fortaflex Surgical SlingOrganogenesis, Inc. · 510(k) 2002
- OviTex PRS (Long-Term Resorbable)TELA Bio, Inc. · 510(k) 2024
- Gentrix Surgical Matrix, Gentrix Surgical Matrix HiatalAcell, Inc. · 510(k) 2019
- Propatch Soft Tissue Repair MatrixCryolife, Inc. · 510(k) 2012
- Depuy Restore Orthobiologic Soft Tissue ImplantDePuy Orthopaedics, Inc. · 510(k) 2007
- Bioblanket Surgical MeshKensey Nash Corporation · 510(k) 2006
- VersaWrapAlafair Biosciences, Inc. · 510(k) 2021
- Colorado Therapeutics Xenograft ImplantColorado Therapeutics, LLC · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.